MENU
+Compare
PLSE
Stock ticker: NASDAQ
AS OF
Dec 24 closing price
Price
$14.86
Change
+$0.28 (+1.92%)
Capitalization
1.01B

PLSE Pulse Biosciences Forecast, Technical & Fundamental Analysis

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue... Show more

PLSE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for PLSE with price predictions
Dec 24, 2025

PLSE in +7.01% Uptrend, advancing for three consecutive days on December 19, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PLSE advanced for three days, in of 249 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where PLSE's RSI Indicator exited the oversold zone, of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 12, 2025. You may want to consider a long position or call options on PLSE as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PLSE just turned positive on December 01, 2025. Looking at past instances where PLSE's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 127 cases where PLSE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 50 cases where PLSE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

PLSE moved below its 50-day moving average on December 23, 2025 date and that indicates a change from an upward trend to a downward trend.

The 50-day moving average for PLSE moved below the 200-day moving average on December 03, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PLSE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PLSE broke above its upper Bollinger Band on December 19, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PLSE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.870) is normal, around the industry mean (9.534). P/E Ratio (0.000) is within average values for comparable stocks, (167.335). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.546). PLSE has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). PLSE's P/S Ratio (10000.000) is very high in comparison to the industry average of (112.419).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PLSE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
PLSE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

PLSE is expected to report earnings to rise 62.72% to -33 cents per share on March 26

Pulse Biosciences PLSE Stock Earnings Reports
Q4'25
Est.
$-0.33
Q3'25
Beat
by $0.07
Q4'24
Missed
by $0.07
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.04
The last earnings report on November 05 showed earnings per share of -20 cents, beating the estimate of -27 cents. With 64.57K shares outstanding, the current market capitalization sits at 1.01B.
A.I. Advisor
published General Information

General Information

a development stage company, which manufactures surgical and medical instruments

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
3957 Point Eden Way
Phone
+1 510 906-4600
Employees
56
Web
https://www.pulsebiosciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DLRHX25.510.16
+0.63%
Nomura Healthcare Fund Class R
RWGFX4.250.02
+0.47%
Wedgewood Retail
HTSCX10.110.03
+0.30%
Hartford Small Cap Value C
DFSIX53.160.15
+0.28%
DFA US Sustainability Core 1
NRMGX15.120.02
+0.13%
Neuberger Mid Cap Growth R6

PLSE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PLSE has been loosely correlated with CERS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PLSE jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLSE
1D Price
Change %
PLSE100%
+1.92%
CERS - PLSE
38%
Loosely correlated
N/A
BLFS - PLSE
36%
Loosely correlated
-0.20%
SMTI - PLSE
34%
Loosely correlated
+0.04%
STXS - PLSE
33%
Poorly correlated
-0.82%
CLPT - PLSE
32%
Poorly correlated
+0.84%
More

Groups containing PLSE

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLSE
1D Price
Change %
PLSE100%
+1.92%
Pharmaceuticals: Other
industry (102 stocks)
33%
Poorly correlated
+0.30%
Pharmaceuticals
industry (375 stocks)
29%
Poorly correlated
+0.36%